JP2004528088A - 乳管から材料を採取するための装置、方法、およびシステム - Google Patents
乳管から材料を採取するための装置、方法、およびシステム Download PDFInfo
- Publication number
- JP2004528088A JP2004528088A JP2002580813A JP2002580813A JP2004528088A JP 2004528088 A JP2004528088 A JP 2004528088A JP 2002580813 A JP2002580813 A JP 2002580813A JP 2002580813 A JP2002580813 A JP 2002580813A JP 2004528088 A JP2004528088 A JP 2004528088A
- Authority
- JP
- Japan
- Prior art keywords
- duct
- hub
- catheter
- fluid
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 70
- 239000000463 material Substances 0.000 title claims abstract description 62
- 239000008267 milk Substances 0.000 title claims description 96
- 210000004080 milk Anatomy 0.000 title claims description 96
- 238000003306 harvesting Methods 0.000 title description 3
- 239000012530 fluid Substances 0.000 claims abstract description 223
- 210000000481 breast Anatomy 0.000 claims abstract description 72
- 230000001413 cellular effect Effects 0.000 claims abstract description 33
- 239000007924 injection Substances 0.000 claims description 59
- 238000002347 injection Methods 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 30
- 238000001802 infusion Methods 0.000 claims description 26
- 238000004140 cleaning Methods 0.000 claims description 25
- 230000002262 irrigation Effects 0.000 claims description 22
- 238000003973 irrigation Methods 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 14
- 238000005070 sampling Methods 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- 239000012781 shape memory material Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 6
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004194 lidocaine Drugs 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 60
- 210000002445 nipple Anatomy 0.000 description 37
- 239000000203 mixture Substances 0.000 description 32
- 210000005070 sphincter Anatomy 0.000 description 20
- 206010006187 Breast cancer Diseases 0.000 description 14
- 208000026310 Breast neoplasm Diseases 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 14
- 238000004873 anchoring Methods 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 210000002919 epithelial cell Anatomy 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- -1 portions Substances 0.000 description 7
- 230000002380 cytological effect Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 206010006256 Breast hyperplasia Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 206010020718 hyperplasia Diseases 0.000 description 5
- 206010016825 Flushing Diseases 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 239000002872 contrast media Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 239000003978 infusion fluid Substances 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 206010006223 Breast discharge Diseases 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 208000006994 Precancerous Conditions Diseases 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 229940119743 dextran 70 Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940050526 hydroxyethylstarch Drugs 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 239000000819 hypertonic solution Substances 0.000 description 2
- 229940021223 hypertonic solution Drugs 0.000 description 2
- 201000010759 hypertrophy of breast Diseases 0.000 description 2
- 239000000815 hypotonic solution Substances 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 2
- 229960000511 lactulose Drugs 0.000 description 2
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 238000009607 mammography Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VEMLQICWTSVKQH-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;propane-1,2,3-triol Chemical compound OCC(O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O VEMLQICWTSVKQH-BTVCFUMJSA-N 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000006402 Ductal Carcinoma Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 210000004293 human mammary gland Anatomy 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000024312 invasive carcinoma Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000003339 pneumostatic effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0041—Detection of breast cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Sampling And Sample Adjustment (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Surgical Instruments (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28363601P | 2001-04-16 | 2001-04-16 | |
| PCT/US2002/009583 WO2002083005A2 (en) | 2001-04-16 | 2002-03-29 | Devices, methods and systems for collecting material from a breast duct |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004528088A true JP2004528088A (ja) | 2004-09-16 |
| JP2004528088A5 JP2004528088A5 (enExample) | 2005-12-22 |
Family
ID=23086926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580813A Pending JP2004528088A (ja) | 2001-04-16 | 2002-03-29 | 乳管から材料を採取するための装置、方法、およびシステム |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1379175B1 (enExample) |
| JP (1) | JP2004528088A (enExample) |
| AT (1) | ATE394994T1 (enExample) |
| AU (1) | AU2002258642B2 (enExample) |
| DE (1) | DE60226584D1 (enExample) |
| WO (1) | WO2002083005A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2400037A (en) * | 2003-03-31 | 2004-10-06 | Psimedica Ltd | Device made of silicon and method for collecting mammary fluid |
| US7174923B2 (en) * | 2003-10-31 | 2007-02-13 | Codman & Shurtleff, Inc. | Refill kit for an implantable pump |
| JP2007518478A (ja) * | 2003-12-23 | 2007-07-12 | サイティック コーポレーション | 医療行為を実行するために乳管にアクセスするための医療器具およびその使用方法 |
| CN103394153B (zh) * | 2013-07-26 | 2015-12-23 | 赵凯华 | 乳腺导管插管器 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4023559A (en) * | 1975-01-28 | 1977-05-17 | Smith & Nephew (Australia) Pty. Limited | Sampling catheter device |
| US4737152A (en) * | 1986-07-02 | 1988-04-12 | Becton, Dickinson And Company | Catheter assembly |
| US5215527A (en) * | 1991-12-12 | 1993-06-01 | Becton, Dickinson And Company | Catheter introducer assembly |
| WO1999065546A1 (en) * | 1998-06-19 | 1999-12-23 | A-Med Systems, Inc. | Apparatus and methods for entering cavities of the body |
| WO2000020031A1 (en) * | 1998-10-02 | 2000-04-13 | Windy Hill Technology, Inc. | Methods for identification, diagnosis, and treatment of breast cancer |
| IL144033A0 (en) * | 1998-12-28 | 2002-04-21 | Pro Duct Health Inc | Devices, methods and systems for collecting material from a breast duct |
-
2002
- 2002-03-29 DE DE60226584T patent/DE60226584D1/de not_active Expired - Lifetime
- 2002-03-29 AT AT02728598T patent/ATE394994T1/de not_active IP Right Cessation
- 2002-03-29 AU AU2002258642A patent/AU2002258642B2/en not_active Ceased
- 2002-03-29 JP JP2002580813A patent/JP2004528088A/ja active Pending
- 2002-03-29 WO PCT/US2002/009583 patent/WO2002083005A2/en not_active Ceased
- 2002-03-29 EP EP02728598A patent/EP1379175B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002083005A3 (en) | 2002-12-12 |
| HK1060838A1 (en) | 2004-08-27 |
| EP1379175B1 (en) | 2008-05-14 |
| WO2002083005A2 (en) | 2002-10-24 |
| AU2002258642B2 (en) | 2006-08-31 |
| ATE394994T1 (de) | 2008-05-15 |
| DE60226584D1 (de) | 2008-06-26 |
| EP1379175A2 (en) | 2004-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6689070B2 (en) | Devices, methods and systems for collecting material from a breast duct | |
| CA2327514C (en) | Method and kit for obtaining fluids and cellular material from breast ducts | |
| US20080045924A1 (en) | Sonohysterography and biopsy catheter | |
| US7229420B2 (en) | Medical instrument for accessing a breast duct for performing a medical procedure | |
| CA2912147C (en) | Three lumen balloon catheter apparatus | |
| US20040153001A1 (en) | Devices, methods and systems for collecting material from a breast duct | |
| US7276047B2 (en) | Ductal lavage microcatheter with user activated valve and Nitinol introducer | |
| AU2002258642B2 (en) | Devices, methods and systems for collecting material from a breast duct | |
| AU2002258642A1 (en) | Devices, methods and systems for collecting material from a breast duct | |
| EP1703923B1 (en) | Medical instrument for accessing a breast duct for performing a medical procedure | |
| HK1060838B (en) | Devices for collecting material from a breast duct | |
| US20050137524A1 (en) | Ductal lavage catheter having an off-axis tip | |
| US7195601B2 (en) | Method of opening a ductal sphincter using controlled fluid pressure | |
| HK1095102B (en) | Medical instrument for accessing a breast duct for performing a medical procedure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050124 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050124 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20050418 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080324 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080623 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080723 |